Promising developments include noninvasive biomarkers: proteomic studies show DN-specific urinary peptides (collagen fragments, nephrin, podocin), while tubular injury markers like kidney injury molecule-1 (KIM-1) may indicate ischemic injury seen in HN [131]. The gene discussed is HAVCR1; the disease is liver dysplastic nodule.